DK1107787T3 - Salmonella typhi vaccinesammensætning - Google Patents
Salmonella typhi vaccinesammensætningInfo
- Publication number
- DK1107787T3 DK1107787T3 DK99944497T DK99944497T DK1107787T3 DK 1107787 T3 DK1107787 T3 DK 1107787T3 DK 99944497 T DK99944497 T DK 99944497T DK 99944497 T DK99944497 T DK 99944497T DK 1107787 T3 DK1107787 T3 DK 1107787T3
- Authority
- DK
- Denmark
- Prior art keywords
- vaccine composition
- salmonella typhi
- typhi vaccine
- salmonella
- composition
- Prior art date
Links
- 229940124857 Salmonella typhi vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/255—Salmonella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9818910.3A GB9818910D0 (en) | 1998-08-28 | 1998-08-28 | Novel formulation |
GBGB9909080.5A GB9909080D0 (en) | 1999-04-20 | 1999-04-20 | Novel formulations |
PCT/EP1999/006202 WO2000012129A2 (en) | 1998-08-28 | 1999-08-24 | Salmonella typhi vaccine compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1107787T3 true DK1107787T3 (da) | 2003-09-01 |
Family
ID=26314288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99944497T DK1107787T3 (da) | 1998-08-28 | 1999-08-24 | Salmonella typhi vaccinesammensætning |
Country Status (11)
Country | Link |
---|---|
EP (2) | EP1107787B1 (da) |
JP (1) | JP2002525277A (da) |
AR (1) | AR023643A1 (da) |
AT (1) | ATE240118T1 (da) |
AU (1) | AU5739999A (da) |
CA (1) | CA2341703A1 (da) |
DE (1) | DE69907921T2 (da) |
DK (1) | DK1107787T3 (da) |
ES (1) | ES2193742T3 (da) |
PT (1) | PT1107787E (da) |
WO (1) | WO2000012129A2 (da) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2828406B1 (fr) * | 2001-08-08 | 2005-06-24 | Aventis Pasteur | Composition vaccinale bivalente havi |
EP2066344B2 (en) | 2006-09-07 | 2016-06-29 | GlaxoSmithKline Biologicals S.A. | Inactivated Poliovirus combination vaccine |
SG11201501391YA (en) | 2012-09-10 | 2015-03-30 | Glycovaxyn Ag | Bioconjugates comprising modified antigens and uses thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5204098A (en) * | 1988-02-16 | 1993-04-20 | The United States Of America As Represented By The Department Of Health And Human Services | Polysaccharide-protein conjugates |
RU2111012C1 (ru) * | 1997-04-15 | 1998-05-20 | Вячеслав Леонидович Львов | Вакцинный препарат для профилактики брюшного тифа |
-
1999
- 1999-08-24 DE DE69907921T patent/DE69907921T2/de not_active Revoked
- 1999-08-24 AT AT99944497T patent/ATE240118T1/de not_active IP Right Cessation
- 1999-08-24 AU AU57399/99A patent/AU5739999A/en not_active Abandoned
- 1999-08-24 WO PCT/EP1999/006202 patent/WO2000012129A2/en not_active Application Discontinuation
- 1999-08-24 EP EP99944497A patent/EP1107787B1/en not_active Revoked
- 1999-08-24 EP EP02079708A patent/EP1285666A1/en not_active Withdrawn
- 1999-08-24 DK DK99944497T patent/DK1107787T3/da active
- 1999-08-24 ES ES99944497T patent/ES2193742T3/es not_active Expired - Lifetime
- 1999-08-24 JP JP2000571026A patent/JP2002525277A/ja active Pending
- 1999-08-24 CA CA002341703A patent/CA2341703A1/en not_active Abandoned
- 1999-08-24 PT PT99944497T patent/PT1107787E/pt unknown
- 1999-08-26 AR ARP990104274A patent/AR023643A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP1285666A1 (en) | 2003-02-26 |
AU5739999A (en) | 2000-03-21 |
EP1107787B1 (en) | 2003-05-14 |
CA2341703A1 (en) | 2000-03-09 |
ATE240118T1 (de) | 2003-05-15 |
AR023643A1 (es) | 2002-09-04 |
DE69907921T2 (de) | 2004-03-11 |
DE69907921D1 (de) | 2003-06-18 |
ES2193742T3 (es) | 2003-11-01 |
EP1107787A2 (en) | 2001-06-20 |
JP2002525277A (ja) | 2002-08-13 |
WO2000012129A3 (en) | 2000-06-29 |
PT1107787E (pt) | 2003-07-31 |
WO2000012129A2 (en) | 2000-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20004758D0 (no) | Vaksinesammensetning | |
DE69933200D1 (de) | Kombinierte impfstoffzusammensetzungen | |
DE60045324D1 (de) | Impfstoffzusammensetzung | |
NO20026175L (no) | Vaksinesammensetning | |
EP1083926A4 (en) | VACCINE | |
NO20003303D0 (no) | Vaksine | |
BR9711853A (pt) | Vacinas | |
ID26720A (id) | Komposisi oral | |
NO985460D0 (no) | Limsammensetning | |
ID26186A (id) | Komposisi sampo | |
ID28694A (id) | Komposisi sampo | |
DK1267899T3 (da) | ssa-inaktiverede salmonellavacciner | |
ID17860A (id) | Komposisi vaksin | |
PT1139764E (pt) | Composicao adjuvante | |
DE69942892D1 (de) | Gaserzeugende zusammensetzung | |
DE69928862D1 (de) | Zusammensetzung | |
HUP0302612A3 (en) | Salmonella vaccine | |
FI972054L (fi) | Immunogeenisiä koostumuksia | |
HUP0005010A3 (en) | Salmonella vaccine | |
IS5694A (is) | Bóluefni | |
ID29857A (id) | Vaksin oral terhadap diare | |
DK1107787T3 (da) | Salmonella typhi vaccinesammensætning | |
GB9801870D0 (en) | Vaccine composition | |
ID26295A (id) | Komposisi keras-ultraviolet | |
ID28359A (id) | Komposisi |